Study Looks at Impact of Children's Exposure to Lead in the United States

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 4, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Dec. 4, 2024 -- Children's exposure to lead in the United States has had a significant impact on mental illness symptomatology and disadvantageous personality differences, according to a study published online Dec. 4 in the Journal of Child Psychology and Psychiatry.

Michael J. McFarland, Ph.D., from Florida State University in Tallahassee, and colleagues combined serial, cross-sectional blood-lead level (BLL) data from National Health and Nutrition Examination Surveys with historic leaded-gasoline data to estimate U.S. childhood BLLs from 1940 to 2015. Population mental health symptom elevations from known lead-psychopathology associations were calculated.

Assuming the published lead-psychopathology associations are causal, the researchers estimated that the U.S. population gained 602 million General Psychopathology factor points arising from leaded gasoline by 2015, reflecting an increase of 0.13 standard deviations in overall liability to mental illness and an estimated 151 million excess mental disorders due to exposure to lead. Standard deviation increases of 0.64 and 0.42 in population-level internalizing symptoms and attention-deficit/hyperactivity disorder symptoms, respectively, were identified on examination of specific disorder-domain symptoms. A 0.14-standard deviation increase in population-level neuroticism was seen, as was a 0.20-standard deviation decrease in conscientiousness. Cohorts born from 1966 to 1986 had the most pronounced lead-associated mental health and personality differences.

"A significant burden of mental illness symptomatology and disadvantageous personality differences can be attributable to U.S. children’s exposure to lead over the past century," the authors write. "The contribution of legacy lead exposures to population health and disease may be much larger than previously assumed."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords